Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer
Status:
Recruiting
Trial end date:
2026-10-01
Target enrollment:
Participant gender:
Summary
This research is being done to study the effects of the combination of ipilimumab, nivolumab,
and radiation therapy in people with microsatellite stable pancreatic cancer.
The names of the study interventions involved in this study are:
- Ipilimumab
- Nivolumab
- Radiation Therapy